# Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

> **NCT00993382** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 486 (actual)

## Conditions studied

- Arrhythmia Prophylaxis
- Ventricular Arrhythmia

## Interventions

- **DRUG:** Celivarone
- **DRUG:** Amiodarone
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT00993382
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 486 (ACTUAL)
- **Last updated:** 2016-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993382, "Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00993382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
